Brief: Bioretec's Hybrid Composite Patent Approved In Europe
Sept 8 (Reuters) - AstraZeneca PLC AZN.L :
* BIORETEC'S HYBRID COMPOSITE PATENT HAS BEEN APPROVED IN EUROPE
Source text for Eikon: ID:nWkr5v8PTc
Further company coverage: AZN.L
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))